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Abstract The aim of the study was to investigate whether
there are unique pathotypes of Escherichia coli capable of
transmission from the gastrointestinal tract to the vascular
bed. The study included E. coli strains isolated from clinical
materials collected from 115 patients suffering from
haematologic malignancies diagnosed with bacteraemia. The
genotyping techniques established that 89 E. coli isolates from
the blood had the same genotype as the E. coli from the pa-
tient’s bowel. The presence of 21 genes encoding virulence
factors typical of various E. coli pathotypes and their relation-
ship with the phylogenetic group was established. One-
dimensional analysis showed that the focG gene occurred
more frequently in the control bowel group, while the
ampicillin-resistant afa/dr E. coli were associated with
bacteraemia. Blood isolates with the highest occurrence of
virulence factors belonged to pathogenic group B2 and non-
pathogenic group A. The co-occurrence of multiple genes
encoding papC, sfa, usp and cnf1 virulence factors probably
predisposes E. coli to translocation from the gastrointestinal
tract to the vascular bed in the group of patients with
haematologic malignancies. Based on clustering analysis,
dominance of the most virulent strains assigned to the cluster
with seven virulence factors encoded by the following genes,
papC, sfaD/E, cnf1, usp, agn43, hlyA and iutA, was found.
The obtained results enforce the previously proposed concept
of bowel–blood translocation and further expand our hypoth-
esis by defining the unique virulence characteristics of E. coli
isolates, which predispose them to bowel colonisation or
translocation and bacteraemia in this group of patients.
Introduction
Patients with proliferative disorders of the haematopoietic sys-
tem are at a higher risk of developing bacteraemia and
septicaemia [1–6]. Although the underlying mechanisms of
bacteraemia are under-investigated, it is considered that both
the primary disease and the treatment may contribute to the
bacteraemia. The source of dissemination of bacteria is usual-
ly an extra-intestinal infection, such as respiratory, urinary
tract or wound [2]. This is particularly observed in patients
after the transplant of haematopoietic stem cells, when immu-
nity is severely impaired and/or following cytostatic and im-
munosuppressive treatment. Research conducted in this group
of patients has shown a growing number of bloodstream in-
fections with Gram-negative rods, where Escherichia coliwas
the dominant aetiologic factor for bacteraemia and
septicaemia. Mortality in patients with documented E. coli
bacteraemia is high; depending on the research centre, it
may reach even 37 % [3–5, 7–9].
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We have recently reported a previously unrecognised
mechanism of recurrent bacteraemia in patients with
leukaemic malignancy [10]. Our study indicated that, in
70 % of patients, the bowel was the primary source of the
pathogen which led to a new bacteraemic episode. The iden-
tical DNA fingerprints of E. coli from the bowel and blood in
the absence another source of infection was consistent with
interpretation that the recurrent bacteraemia occurred due to
direct translocation of E. coli present in the bowel to the blood
system.
It is considered that patients with haematologic malignan-
cies display a varying degree of immune and intestinal barrier
dysfunction [11–13]. Therefore, the significant question that
remains to be addressed is whether the E. coli bowel to blood
translocation in patients with malignant diseases occurs with a
random commensal/coloniser, consistent with immune/
intestine dysfunction, or with E. coli that carry specific viru-
lence factors. In this instance, virulence factors would facili-
tate E. coli bowel mucosa translocation and invasion to the
blood system. This question is highly relevant because the
generated knowledge would allow us to design specific pre-
ventive strategies and reduce patient mortality due to E. coli
bacteraemia.
E. coli pathogenesis is mediated by a broad spectrum of
virulence factors specific to enteric/gastrointestinal/diarrhoeal
pathogens (enterotoxins) or to extraintestinal E. coli (ExPEC)
pathogens [14–17]. Only 10–20 % of healthy people carry
ExPEC strains that stably colonise the host’s intestines [18].
ExPEC virulence is mediated by adhesins, invasins, toxins,
polysaccharide coatings, siderophores and other factors
targeting immune cells in the blood. Such virulence factors
help to colonise the surfaces of host cells, avoid and/or abolish
the host defence mechanism, damage and/or enter host cells or
tissues, including blood components, and provoke a harmful
immune response, which increases the risk of a disease.
The present study was conducted on a previously untested
patient population. E. coli isolates from the blood and stool of
patients with malignant diseases of the blood system were
tested by DNA fingerprinting combined with a polymerase
chain reaction (PCR) analysis of E. coli virulence factors.
The obtained results enforce the previously proposed concept
of bowel–blood translocation and further expand our hypoth-
esis by defining the unique virulence characteristics of E. coli
isolates which predispose them to bowel colonisation or trans-
location and bacteraemia in this group of patients.
Materials and methods
Bacterial strains and microbiological procedures
The study involved 115 patients treated for haematologic ma-
lignancies in the Department of Haematology and
Transplantation at the University Clinical Center, in the years
2006–2012. The clinical analysis was retrospective in nature,
and all clinical data were obtained from medical records. The
median age of the patients was 49.8 years (range; 19–84 years)
and 62 were male. The most common underlying
haematologic malignancy was acute myelogenous leukaemia,
observed in 59 patients. Eighteen patients underwent lympho-
cytic leukaemia, 11 non-Hodgkin’s lymphomas and 17 multi-
ple myeloma. The basis for the selection of E. coli blood
isolates for the investigation were clinically and microbiolog-
ically confirmed bacteraemia with E. coli aetiology, isolation
of bacteria from blood samples, with the simultaneous isola-
tion of the microorganism from the stool or anal swab. Pa-
tients were selected for which the result of the urine culture
was negative [<1,000 colony-forming units (CFU)/mL] and
for which there was no alternative primary site of infection.
Out of the 115 patients with bacteraemia gathered, the collec-
tion included a total of 1,411 E. coli isolates: on average, each
patient is represented by one blood isolate and up to ten bowel
E. coli isolates. In the design of the study, we adopted the
following principle: after taking into account differences in
the macroscopic assessment of bacterial colony morphology,
only different E. coli isolates were included, usually one blood
and three or more different bowel isolates. As described be-
low, E. coli isolates from patients with bacteraemia were ge-
notyped and divided into two study groups: group 1, E. coli
isolates from the blood, which had a counterpart isolate in the
bowel that was identical to the blood DNA fingerprint
(blood+/bowel+), and control group 2 comprising the remain-
ing bowel isolates with DNA fingerprints that were different
to those in blood and represented E. coli isolates which
persisted in the bowel but, presumably, were not able to trans-
locate from the bowel to blood (blood−/bowel+).
The study of the biochemical characteristics for the 1,411
isolates of E. coli were performed on the basis of 42 freeze-
dried substrates in panelMicroScan®Rapid Negative ID Type
4, read with the help of automated WalkAway SI used for
species identification and susceptibility testing of microorgan-
isms, using microanalysis technology for the rapid identifica-
tion of fluorochromes (MicroScan Rapid Fluorogenic Identi-
fication). In all cases, the correctness of E. coli identification
was 99.99 %.
Genotyping by PCR MP and PFGE methods
Genomic DNAwas isolated from individual bacterial colonies
using a commercial kit (Genomic DNA Kit, ISOLATE II
Bioline). The polymerase chain reaction melting profiles
(PCRMP) procedure was carried out according to the method
described for E. coli isolates by Krawczyk et al. [19]. Rela-
tionships between strains from blood and the gastrointestinal
tract were also confirmed by studying the pulsed-field electro-
phoresis (PFGE) patterns of genomic DNA after restriction by
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XbaI according the CHEF Mapper® XA Bio-Rad manual
protocol.
Determination of E. coli phylogenetic group (phylogroup)
The membership to a phylogenetic group of each E. coli strain
was studied according to Clermont et al.’s method based on
multiplex PCR using three pairs of primers [20].
PCR screening of virulence genes
The three multiplex PCRs were validated for 12 virulence
genes as a home-made test and one commercial multiplex
PCR test for seven virulence genes. Next to this, two genes
were separately amplified as a simplex. In cases of doubt, the
multiplex PCR experiments were repeated in a simplex PCR
system. Details of the primer sequences and predicted sizes of
the amplified products have been described previously
[14–16, 21–29]. Primers for each virulence factor were first
validated individually by the use of template DNA from ap-
propriate positive and negative control strains. The virulence
factors characteristic mainly for the uropathogenic strains
(UPEC) were included in multiplex PCR system I: P fimbriae
assembly outer membrane usher (papC gene), S fimbriae
(sfaD/E gene), type 1 fimbriae (fimG/H gene), cytotoxic
necrotising factor 1 (cnf1 gene), uropathogen-specific protein
Usp (usp gene), haemolysin toxin protein (hlyA gene). Reac-
tions were carried out according to Adamus-Białek et al. [21].
In a separate PCR assay, the presence of Dr fimbriae (draC–
D) was tested [27].
In multiplex PCR system II, the sequence of three fragment
genes, kspMTII [23] (synthesis capsule, group II), iha [28]
(enterobactin Iha-iron-regulated gene homologue adhesion)
and focG [24, 28] (F1C fimbriae), were amplified. In multi-
plex PCR system III, the sequence of three fragment genes,
iutA [25] (aerobactin receptor), fyuA [26] (yersiniabactin re-
ceptor) and ibeA [23, 24] (invasion of brain endothelium A),
were amplified.
For the detection of virulence genes typical for
diarrhoeagenic E. coli (DEC), the commercial DEC PCR Kit
(Statens Serum Institute, Denmark) was used. In this multi-
plex PCR system IV, the detection of vtx1 and vtx2
(verocytotoxin strains, VTEC), eae (EPEC strains), eltA, estA-
human or estA-porcine (ETEC strains), and ipaH (EIEC
strains) were included. An agn43 gene was detected by sim-
plex PCR according to Kotlowski et al. [29].
Statistical analysis
Data were statistically analysed using the Microsoft Excel
2007 program. Statistical testing was done using the SPSS
Statistics 19 program. In order to select the characteristics of
E. coli strains that predispose to translocation from the
gastrointestinal tract into the blood, we performed a Chi-
square analysis. p-Values less than 0.05 were considered to
be significant. Cluster analysis was performed using the k-
means method (QUICK CLUSTER).
Results
Genotyping
The study group included a collection of E. coli isolates ob-
tained from clinical materials from a group of 115 adult pa-
tients with blood malignancy with microbiologically and clin-
ically documented E. coli bacteraemia. On the basis of the
genotyping results, E. coli isolates were divided into two
groups: group 1, 89 E. coli isolates from the blood which
had a counterpart isolate in the bowel that was identical to
the blood DNA fingerprint (blood+/bowel+) and control
group 2 comprising the remaining 146 E. coli bowel isolates
with DNA fingerprints that were different to those in blood
and represented E. coli isolates in the bowel but absent in
blood: presumably, E. coli isolates of group 2 were not able
to translocate from the bowel to blood (blood−/bowel+). The
remaining 50 isolates from blood, for which the genotypes
were not found among isolates from the bowel (blood+/bow-
el−), were excluded from this evaluation. We consider that
these 50 isolates originated either from an unknown extrain-
testinal source or were underrepresented among the bowel
isolates. Strains of blood+/bowel+ and blood−/bowel+ as a
control group were further analysed.
Prevalence of virulence factor genes
The unidirectional analysis of PCR-based detection of genes
encoding the examined E. coli virulence factors (Table 1) in-
dicates that only the afa/dr region predominated in blood iso-
lates; 16 % of strains from blood vs. 5 % in the control bowel
group (p=0.009). In contrast, the focG gene (encoding F1C
fimbriae) was more often identified among control bowel
colonisers (p-value=0.001); 36 % of the control blood−/bow-
el+ group strains vs. 17 % of the blood+/bowel+ isolates; note
that all blood isolates with corresponding colon isolates
displayed identical virulence patterns.
No genes encoding virulence factors characteristic of
DEC were detected in the PCR reactions in tested blood
isolates (data not shown). The lack of these virulence
factors was also confirmed by serological tests conduct-
ed (data not shown). An intriguing possibility exists that
F1C fimbriae could enhance bowel colonisation, while
invasion coding afa/dr could contribute to translocation
to the bloodstream.
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Multidimensional analysis of the occurrence of virulence
factors (co-occurrence)
As our previous report [30] indicated that the translocation to
blood may be increased by the presence of Dr adhesins to-
gether with P fimbriae in patients with urosepsis, we evaluated
the relationship between multiple virulence factors and trans-
location in patients with haematologic malignancies. As
shown in Table 2, the following pairs of genes, hlyA + iutA,
agn43 + papC, focG + fimG, kspMTII + agn43, cnf1 + papC,
cnf1 + sfa, usp + papC, usp + sfa, iutA + agn43, were present
at a higher frequency among blood+/bowel+ isolates, in par-
ticular, the cnf1 + papC and usp + papC pairs, for which the p-
values were 0.009 and 0.001, respectively. The co-occurrence
of ibeA + iutA genes was more frequently observed for isolates
from the control blood−/bowel+ group.
We then further evaluated the relationship between multi-
ple virulence genes and translocation. Based on the co-
occurrence of four virulence factors, papC, sfa, usp and
cnf1, 16 profiles of co-occurrence were distinguished in each
tested group of strains (Fig. 1). It was observed that profile 16
(all four factors positive) was the only one that was
significantly more frequent in the blood+/bowel+ than in the
blood−/bowel+ isolates groups (27 and 15 %, respectively).
The co-occurrence of multiple genes encoding virulence fac-
tors, papC, sfa, usp and cnf1, among blood+/bowel+ probably
predisposes E. coli to translocation from the gastrointestinal
tract to the blood system in the group of patients with
haematologic malignancies.
The two most numerous profiles, 1 and 16, were also
analysed for the co-occurrence of additional virulence factors
(Table 3). Statistically significant differences were shown for
the co-occurrence of fimG/H and hlyA (p=0.007 and p<0.001,
respectively).
Profile 1 was characterised by a higher occurrence of the
fimG/H gene among blood isolates (blood+/bowel+ group) as
compared to the blood−/bowel+ group, which was treated as the
control (83 and 42 %, respectively). On the other hand, profile 1
showed negligible presence of the hlyA gene, in contrast to
profile 16 (blood+/bowel+ group, 58 %; blood−/bowel+ group,
82 %). In profile 16, the fimG/H gene occurred at an equally
high level, regardless of the group (blood+/bowel+, 75%; blood
−/bowel+ group, 73 %). In contrast, the hlyA gene in profile 16
was less frequent in blood than in the control bowel group
(blood+/bowel+ group, 58 %; blood−/bowel+ group, 82 %).
To confirm the significance of the selected virulence factors
based on multidimensional analyses for strains isolated from
blood, cluster analysis using the k-means method (QUICK
CLUSTER) was performed. Six clusters were created for
eight virulence factors (Table 4) and the number of observa-
tions was specified for each cluster. Based on clustering anal-
ysis within the specified group, dominance of the most viru-
lent strains assigned to the cluster with seven virulence factors
Table 1 Unidirectional analysis of polymerase chain reaction (PCR)-









n %b %c n %b %c
afa/dr 14 16 64 8 5 36 0.009
fimG/H 59 66 39 91 62 61 0.540
sfa 47 53 42 66 45 58 0.258
papC 45 51 44 57 39 56 0.084
hlyA 28 31 42 38 26 58 0.369
usp 43 48 36 76 52 64 0.578
cnf1 44 49 39 69 47 61 0.746
fyuA 57 64 38 92 63 62 0.874
iutA 67 75 39 104 71 61 0.499
ibeA 26 29 30 61 42 70 0.053
iha 37 42 41 53 36 59 0.420
focG 15 17 22 53 36 78 0.001
kspMTII 33 37 43 44 30 57 0.271
agn43 72 81 40 107 73 60 0.184
a afa/dr Dr fimbriae (afa/draB–C); fimG/H type 1 fimbriae (fimG/fimH);
sfa S fimbriae (sfaD/sfaE); papC P fimbriae; hlyA haemolysin; usp-
bacteriocin Usp; cnf1 cytotoxic necrotising factor; fyuA yersiniabactin
receptor; iutA aerobactin receptor; ibeA invasive protein; iha enterobactin
(siderophore receptor and adherence factor); focG F1C fimbriae; kspMTII
protein responsible for capsule formation; agn43 adhesin 43 (biofilm
formation)
b Percent within the group of isolates
c Percent within the virulence factor
Table 2 Two-dimensional analysis of the coexistence of two genes
encoding virulence factors among the investigated E. coli isolates:









n %b n %b
hlyA + iutA 25 28 26 18 0.046
agn43 + papC 39 44 41 28 0.036
focG + fimG/H 14 16 36 25 0.049
ibeA + iutA 20 22 57 39 0.027
kspMTII + agn43 30 34 32 22 0.046
cnf1 + papC 29 33 28 19 0.009
cnf1 + sfa 39 44 50 34 0.040
usp + papC 32 36 32 22 0.001
usp + sfa 35 39 48 33 0.037
iutA + agn43 58 65 74 51 0.019
aVirulence factor names as in the legend of Table 1
b Percent within the group of isolates
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encoded by the following genes, papC, sfaD/E, cnf1, usp,
agn43, hlyA and iutA, was found (cluster 2 in Table 4). This
observation is consistent with the interpretation that dominant
cluster 2 from blood+/bowel+ carried the most virulence fac-
tors and, therefore, was best equipped to translocate to the
blood system. One concern remains that the analysis of pro-
files 1 and 16 in Fig. 1 and Table 3 suggested a surprising
observation that type 1 adhesin contributed to bacteraemia
while haemolysin did not. We consider that an unexpected
lack of association of Hly with virulence resulted from the
altered phylogenetic distribution.
Phylogenetic grouping
For isolates from the blood+/bowel+ group, four phylogenetic
groups were identified: group A, 14 (16 %); group B1, 27
(30 %); group B2, 40 (45 %); and group D, 8 (9 %). The
results were referred to the control group (blood−/bowel+),
where affiliation to group A [30 (21 %)], group B1 [41
(34 %)], group B2 [59 (40 %)] and group D [8 (5 %)] was
found. The affiliation to phylogenetic group proved to be sta-
tistically insignificant (p-value=0.545). The majority of
strains, regardless of the isolation source, belonged to phylo-
genetic group B2, which is considered to be pathogenic. A
relatively large number of strains belonged to phylogenetic
group B1, classified as physiological microflora in the
Fig. 1 Image analysis of co-
occurrence of virulence factors
papC, sfa, usp and cnf1 presented
in the form of a dichotomic key.
The white rectangles indicate the
absence of gene encoding
virulence factors and the black
rectangles indicate the presence
of gene encoding virulence
factors
Table 3 Summary of the percentage of co-occurrence of other
virulence factors for groups blood+/bowel+and blood−/bowel+ and
profiles 1 and 16
Virulence
factora













fimG/H 19/83 18/75 13/42 16/73 0.007
hlyA 1/4 14/58 1/3 18/82 0.001
fyuA 13/57 16/67 16/52 18/82 0.132
iutA 16/70 17/71 25/81 17/77 0.760
ibeA 9/39 7/29 19/61 11/50 0.100
iha 13/57 9/38 15/48 10/45 0.625
focG 4/17 5/21 13/42 9/41 0.117
kspMTII 7/30 12/50 11/35 8/36 0.545
aVirulence factor names as in the legend of Table 1
Table 4 Cluster analysis of E. coli strains of the blood+/bowel+ group.
Six clusters with various profiles of eight virulence factors: papC, sfaD/E,








a 1: no virulence factors; 2: papC, sfaD/E, usp, cnf1, agn43, hlyA, iutA; 3:
sfaD/E, usp, cnf1, agn43; 4: papC, sfaD/E, cnf1, ibeA; 5: papC, agn43,
hlyA, iutA, ibeA; 6: agn43, iutA
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gastrointestinal tract. We consider that group A and B1 isolates
could migrate to the circulatory system in this group of patients,
due to damaged intestinal mucosa caused by therapy with cy-
tostatic medication, ionising radiation and broad-spectrum an-
tibiotics. However, this suggestion requires further verification
for the occurrence of virulence factors (see below).
At the same time, an analysis of phylogenetic affinity was
performed for profiles 1 and 16 of both groups (Table 5).
Regardless of the strain origin, phylogroup B1 was the most
numerous for profile 1 (low frequency of virulence factors),
while phylogroup B2 occurred in the greatest numbers for
profile 16 (high frequency of virulence factors). In addition,
for strains isolated from blood (blood+/bowel+ group) be-
longing to profile 16, there was a much higher percentage of
strains from phylogenetic group A (29 %) as compared to
profile 16 of the control group (18 %). It was shown that the
four groups of strains are statistically significantly different
due to the phylogenetic groups distribution (p=0.033). The
p-value was calculated for strains divided into four groups
(n=100) and phylogenetic groups (rows) (Table 5).
Virulence factors and the phylogenetic group
Table 6 presents the analysis of the virulence factor profiles
among the phylogenetic groups of E. coli strains isolated from
blood (blood+/bowel+ group). Consistent with the predicted
virulence of group B2, the occurrence of the sfa, hlyA, cnf1
and fyuA genes (p=0.010; p<0.001, p=0.009 and p=0.013,
respectively) was statistically significant in phylogenetic
group B2. It was observed that no focG and hlyA genes oc-
curred in strains belonging to phylogenetic group D. Interest-
ingly, commensal group A showed a high frequency of several
virulence genes as fimG/H, papC, sfa and usp, while B1
showed a very low frequency of hlyA. When the results ob-
tained for the blood+/bowel+ group of strains are compared
with the data obtained for the control blood−/bowel+ group
(Table 7), it can be observed that virulence factors were dis-
tributed among phylogenetic groups evenly, with no statisti-
cally dominant virulence factors. An exception was the ibeA
gene characteristic of isolates from the control group of
phylogenetic group B1 (53 %, p-value=0.049). Overall, these
observations support the explanation that, in patients with
haematologic malignancies, virulence factors appear to spread
among commensal E. coli within the patient bowel.
Drug resistance profile
An assessment of the antibiotic resistance profile was per-
formed for pairs of strains from the blood and the gastrointes-
tinal tract (n=89) in the sensitive/resistant categories and min-
imum inhibitory concentration (MIC) values testing. On the
basis of the results obtained, it can be concluded that the tested
strains were sensitive to the majority of the selected antibi-
otics. For 11 antibiotics (piperacillin, piperacillin with tazo-
bactam, cefuroxime, cefotaxime, ceftazidime, cefepime,
imipenem, ertapenem, amikacin, gentamicin and netilmicin),
over 90 % of the tested strains were found to be sensitive. The
largest percentage of resistant strains was observed for ampi-
cillin (44 %), ciprofloxacin and norfloxacin (35 % each). It
was interesting that all 22 strains with the afa/dr virulence
factor gene isolated from both groups were ampicillin resis-
tant. Due to the low frequency of multidrug-resistant strains
among the tested isolates, it can be inferred that these are not
strains of hospital origin. On the other hand, the association of
Dr adhesins with resistance to ampicillin appears to be an
independent risk factor for bacteraemia.
Discussion
Here, we present findings which re-enforce the recently pro-
posed concept that, in patients with haematologic malignancies,
the bowel is a main source of direct E. coli bowel–blood trans-
location and resulting bacteraemia [10]. We further expand our
hypothesis by defining the virulence characteristics of E. coli
bowel–blood colonisers and provided evidence that bowel col-
onisation and risk of translocation and bacteraemia in this group
of patients was associated with E. coli bearing genes encoding
specific sets of colonisation/invasion/toxic factors.
Genotyping analysis of E. coli among 115 patients suffering
from haematologic malignancies, in whom bacteraemia was di-
agnosed, was performed. E. coli isolates with the same genotype
in the blood and the bowel were found in the majority of patients
and were not detected in only 31 patients. 64 % (n=89) of iso-
lates from the blood found their counterparts in the bowel
(blood+/bowel+). The findings are consistent with our previous
report that, in patients with haematologic malignancies, in the
absence of extraintestinal and gastrointestinal source of infection,
the bowel remains the most likely source of E. coli direct trans-
location to the bloodstream [10]. We further investigated an un-
resolved question regardingwhetherE. coli bowel to blood trans-
location in patientswithmalignant diseases occurswith a random
commensal/coloniser or with E. coli that carry specific virulence
Table 5 Summary of the percentage of phylogenetic groups for groups
blood+/bowel+ and blood−/bowel+ and profiles 1 and 16
Phylogenetic
group









A 3/13 7/29 6/19 4/18
B1 11/48 3/13 15/48 4/18
B2 7/30 11/46 9/29 14/64
D 2/9 3/13 1/3 0/0
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Table 6 Analysis of the virulence factor profiles among the phylogenetic groups of E. coli strains of the blood+/bowel+ group
Virulence factora Phylogenetic group p-Value
A (n=14) B1 (n=27) B2 (n=40) D (n=8)
n %b %c n %b %c n %b %c n %b %c
afa/dr 3 21 21 6 43 22 4 29 10 1 7 13 0.521
fim 13 22 93 17 29 63 242 41 60 5 8 63 0.150
sfa 9 19 64 7 15 26 26 55 65 5 11 63 0.010
papG 10 22 71 9 20 33 22 49 55 4 9 50 0.114
hlyA 7 25 50 2 7 7 19 68 48 0 0 0 0.000
usp 9 21 64 11 26 41 19 44 48 4 9 50 0.558
cnf 8 18 57 6 14 22 25 57 63 5 11 63 0.009
fyuA 7 12 50 13 23 48 33 58 83 4 7 50 0.013
iutA 9 13 64 19 28 70 32 48 80 7 10 88 0.497
ibeA 4 15 29 8 31 30 11 42 28 3 12 38 0.955
iha 6 16 43 8 22 30 20 54 50 3 8 38 0.420
focG 3 20 21 5 33 19 7 47 18 0 0 0 0.594
kspMTII 4 12 29 8 24 30 17 52 43 4 12 50 0.541
agn43 10 14 71 19 26 70 35 49 88 8 11 100 0.124
aVirulence factor names as in the legend of Table 1
b Percent within the virulence factor
c Percent within the phylogenetic group
Table 7 Analysis of the virulence factor profiles among the phylogenetic groups of E. coli strains isolated from blood (n=89) and the gastrointestinal
tract (n=146)
Virulence factora Phylogenetic group
A (bn=14/30) B1 (bn=27/49) B2 (bn=40/59) D (bn=8/8)
n %c n %c n %c n %c
afa/dr 3/1 21/3 6/2 22/4 4/5 10/8 1/0 13/0
fim 13/22 93/73 17/26 63/53 24/39 60/66 5/4 63/50
sfa 9/6 d64/20 7/19 26/39 26/37 65/63 5/4 63/50
papG 10/13 71/43 9/16 33/33 22/27 55/46 4/1 50/13
hlyA 7/7 50/23 2/12 7/24 19/18 48/31 0/1 0/13
usp 9/19 64/63 11/21 41/43 19/32 48/54 4/4 50/50
cnf 8/11 57/37 6/20 22/41 25/35 63/59 5/3 63/38
fyuA 7/17 50/57 13/30 48/61 33/41 83/69 4/4 50/50
iutA 9/18 64/60 19/36 70/73 32/44 80/75 7/6 88/75
ibeA 4/14 29/47 8/26 30/d53 11/20 28/34 3/1 38/13
iha 6/10 43/33 8/16 30/33 20/24 50/41 3/3 38/38
focG 3/6 21/20 5/19 19/39 7/27 18/d46 0/1 0/13
kspMTII 4/5 29/17 8/14 30/29 17/22 43/37 4/3 50/38
agn43 10/17 71/57 19/37 70/76 35/48 88/81 8/5 100/63
a Virulence factor names as in the legend of Table 1
bNumber of isolates in the phylogenetic group [blood+/bowel+]/[blood−/bowel+]
c Percent within the phylogenetic group
d p-Value <0.005
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factors. Our data support the hypothesis that unique virulence
genes of E. coli isolates predispose them to translocation and
bacteraemia, while different factors contribute to bowel coloni-
sation in this group of patients.
The results of one-dimensional analysis were statistically
significant for the afa/dr gene, which was associated with
strains of blood+/bowel+ group, and the focG gene, which
occurred more frequently in the control blood−/bowel+ group.
E. coli bearing afa/dr genes coding Dr and Afa adhesins orig-
inate from the gastrointestinal tract as the host’s intestinal mi-
croflora [31], mediate tissue invasion and can cause chronic
urinary tract infections and bacteraemia [30–34]. The present
observation suggests that Dr adhesins can represent an indepen-
dent factor predisposing for bacteraemia in the tested patients.
In this view, the question arises as to whether the presence of
virulent strains with Dr/Afa-type adhesins in the gastrointesti-
nal tract of patients with malignancies and immunosuppression
pose a risk of bacteraemia and require specific eradication strat-
egy. An intriguing possibility exists that F1C fimbriae coded by
the focG gene could enhance bowel colonisation and, perhaps,
restrict E. coli translocation to the bloodstream. This is in ac-
cordance with recent observations that F1C fimbriae contribut-
ed to E. coli persistence in an infant mouse intestinal colonisa-
tion and biofilm formation model [35].
As our previous report indicated, in patients with urosepsis,
the bowel–blood translocation may be increased by the presence
of two adhesins, Dr and P fimbriae. We evaluated the relation-
ship between pairs, clusters of four and clusters ofmore than four
most frequent virulence factors and blood–bowel translocation
in patients with leukaemia [30]. This analysis showed pairs of
genes which differentiated both groups of strains; the pairs of
genes were hlyA + iutA, agn43 + papC, focG + fimG, kspMTII +
agn43, cnf1 + papC, cnf1 + sfa, usp + papC, usp + sfa, iutA +
agn43. The most frequent profiles of four virulence factors were
papC, sfa, usp and cnf1. Profile 16 (all four factors positive) and
profile 1 (all four factors negative) constituted more than half of
all combinations within the blood+/bowel+ group. When the
two most numerous profiles 1 and 16 were analysed for the
co-occurrence of other factors, the association of type 1 fimbriae
but not haemolysin with bacteraemia was noted. We consider
that an unexpected lack of association of hlyAwith bacteremia
resulted from altered phylogenetic distribution. The multidimen-
sional clustering analysis confirmed the dominance of the most
virulent strains assigned to the cluster 2, with seven virulence
factors encoded by the following genes, papC, sfaD/E, cnf1, usp,
agn43, hlyA, iutA, in bacteraemia. This observation is consistent
with the interpretation that dominant cluster 2 from the blood+/
bowel+ group carried most virulence factors, including
haemolysin, and, therefore, was best equipped to translocate to
the blood system. The co-occurrence of multiple factors may
result in a cooperative virulence strategy [30]. P fimbriae have
the ability to bind to epithelial cells and signal inflammatory
response, and the Usp bacteriocin has exonucleolytic properties
and the cytotoxic necrotising factor encoded by cnf1 can cause
cell injury, all of which are rarely encountered in commensal
strains. We consider that, in patients with haematologic malig-
nancies, these bacterial factors, in combination with the host
responses, may result in epithelial cells dysfunction, which be-
come more permeable for microorganisms invasion, allowing
their translocation/transmission.
The correlation of virulent genotypes and the phylogenetic
background for E. coli strains isolated from blood samples in
our material is consistent with the data presented in the literature.
Phylogenetic groupB2 is considered to be pathogenic and rich in
various virulence factors. Our observation showed that, within
the commensal phylogenetic group A, a higher occurrence of
virulence factors was found in strains obtained from the blood
than in strains from the gastrointestinal tract. We consider that an
unexpected lack of association of hlyA with bacteraemia in co-
occurrence with the four most frequent factors resulted from an
altered phylogenetic distribution, e.g. very low or no occurrence
in groups B1 and D. It was noted that the horizontal and vertical
transfer of genes encoding virulence factors leads to high differ-
entiation of the virulence degree among all phylogenetic groups
[16, 30, 32, 36]. No such significant differences were noticed for
the phylogenetic group B2 of strains from the blood and the
control group; in both cases, a high diversity of the combination
of virulence factors was detected. The question arises as to
whether the growth of pathogenic microflora in patients with
haematologic malignancies could lead to enhanced transfer of
genes encoding virulence factors to strains from the commensal
group and, hence, probably a selection of new subtypes ofE. coli
pathogens posing a risk for the general population. In a similar
context, the clonal selection of E. coli pathogen equipped with
virulence factor(s) such as Dr adhesin and antibiotic resistance,
therefore capable of invading/persisting within infected cells and
escaping clearance by antibiotic(s) and disseminating to blood as
previously proposed by Nowickis’ group, may represent a sig-
nificant epidemiologic risk in sensitive populations [37].
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